Effect of Biological Disease-modifying Anti-rheumatic Drugs on Airway and Interstitial Lung Disease in Patients with Rheumatoid Arthritis

OBJECTIVE: Biological disease-modifying anti-rheumatic drugs (bDMARDs) represent an important advance in alleviating rheumatoid arthritis (RA), but their effect on rheumatic airway disease (AD) and interstitial lung disease (ILD) is still unclear. This study was performed to evaluate the association...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Intern Med
Main Authors: Kurata, Izumi, Tsuboi, Hiroto, Terasaki, Mayu, Shimizu, Masaru, Toko, Hirofumi, Honda, Fumika, Ohyama, Ayako, Yagishita, Mizuki, Osada, Atsumu, Ebe, Hiroshi, Kawaguchi, Hoshimi, Takahashi, Hiroyuki, Hagiwara, Shinya, Asashima, Hiromitsu, Kondo, Yuya, Matsumoto, Isao, Sumida, Takayuki
Formato: Artigo
Idioma:Inglês
Publicado em: The Japanese Society of Internal Medicine 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6630137/
https://ncbi.nlm.nih.gov/pubmed/30799358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.2226-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados